BioPharmaceutical Business Intelligence

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information
➤ Start Trial

or, See Plans & Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving leading biopharmaceutical companies globally:

US Department of Justice
Dow
Julphar
Chubb
Covington
Argus Health
Cerilliant
Harvard Business School
Cantor Fitzgerald
Daiichi Sankyo

Generated: January 22, 2018

DrugPatentWatch Database Preview

Vivimed Global Company Profile

« Back to Dashboard

What is the competitive landscape for VIVIMED GLOBAL, and what generic and branded alternatives to VIVIMED GLOBAL drugs are available?

VIVIMED GLOBAL has six approved drugs.



Summary for Vivimed Global
US Patents:0
Tradenames:5
Ingredients:5
NDAs:6

Drugs and US Patents for Vivimed Global

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Vivimed Global METRONIDAZOLE metronidazole TABLET;ORAL 070039-001 Jan 29, 1985 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vivimed Global DONEPEZIL HYDROCHLORIDE donepezil hydrochloride TABLET;ORAL 090551-002 May 31, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vivimed Global AMLODIPINE BESYLATE amlodipine besylate TABLET;ORAL 077516-003 Jul 11, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vivimed Global METRONIDAZOLE metronidazole TABLET;ORAL 070040-001 Jan 29, 1985 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vivimed Global DONEPEZIL HYDROCHLORIDE donepezil hydrochloride TABLET;ORAL 090551-001 May 31, 2011 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vivimed Global AMLODIPINE BESYLATE amlodipine besylate TABLET;ORAL 077516-001 Jul 11, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vivimed Global LOSARTAN POTASSIUM losartan potassium TABLET;ORAL 090382-003 Oct 6, 2010 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vivimed Global ZOLPIDEM TARTRATE zolpidem tartrate TABLET;ORAL 076062-001 Apr 23, 2007 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vivimed Global ZOLPIDEM TARTRATE zolpidem tartrate TABLET;ORAL 076062-002 Apr 23, 2007 DISCN No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Vivimed Global AMLODIPINE BESYLATE amlodipine besylate TABLET;ORAL 077516-002 Jul 11, 2007 AB RX No No ➤ Subscribe ➤ Subscribe ➤ Subscribe
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving leading biopharmaceutical companies globally:

Novartis
Cerilliant
Covington
UBS
Cipla
Baxter
Moodys
US Army
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

botpot